Device Trial Radar · NCT03261063
China Evera MRI® Study
Last checked: Nov 20, 2026Latest source record: Oct 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Oct 12, 2017
Primary completion
Sep 26, 2018
Study completion Sep 26, 2018
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- Aug 24, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a prospective, single arm, non-blinded, multi-site study conducted in mainland China.
Conditions
- Arrhythmias, Cardiac
Interventions
Evera MRI ICD SystemDevice
Subjects are implanted with Evera MRI ICD System and exposed to MRI environment per study requirements
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of successful MRI scansTime frame: 1 Month Follow up visit after MRI Scan Visit
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Hua Xi Hospital (West China Hospital)
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.